Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FNS9T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,337
Award facts
- Contract value 100% obligated
- $34,336.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,336.85 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance to be completed by February 5, 2026, just one day following the award date of February 4, 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company demonstrates significant capability in fulfilling federal pharmaceutical supply requirements, with a robust portfolio of deliveries spanning multiple therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The non-set-aside designation indicates this award was competitively procured, consistent with the company's pattern of winning federal contracts through open competition based on its established capacity to meet government medical supply needs efficiently and reliably.
Quick answers
Who was awarded contract SPE2DR26FNS9T?
SPE2DR26FNS9T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FNS9T worth?
The government has obligated $34,337 on SPE2DR26FNS9T.
Is contract SPE2DR26FNS9T an order under another contract?
Yes. SPE2DR26FNS9T is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNS9T competed?
The extent of competition for SPE2DR26FNS9T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award